已收录 268921 条政策
 政策提纲
  • 暂无提纲
Citrate 4% versus Heparin and the Reduction of Thrombosis Study (CHARTS)
[摘要] Background and objectives: Citrate 4% has antithrombotic and antibacterial properties, which makes it a potentially superior alternative to heparin as an indwelling intraluminal locking agent.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 泌尿医学
[关键词] Bone marrow necrosis;Sickle cell disease;Hyperhemolysis syndrome [时效性] 
   浏览次数:2      统一登录查看全文      激活码登录查看全文